EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Stanniocalcin‐2 inhibits skeletal muscle growth and is upregulated in functional overload‐induced hypertrophy

Arimantas Lionikas iD, Ana I Hernandez Cordero, Audrius Kilikevicius, Andrew M Carroll, Guy S Bewick, Lutz Bunger, Aivaras Ratkevicius, Lora K Heisler, Mette Harboe, Claus Oxvig

Physiological Reports · 2023

DOI: 10.14814/phy2.15793 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Physiological Reports, 2023. Verfasst von Arimantas Lionikas und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK. Hauptthemen laut MEDLINE: Insulin-Like Growth Factor Binding Protein 4, Peptide Hormones. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, Wellcome Trust, Chief Scientist Office.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Stanniocalcin‐2 (STC2) has recently been implicated in human muscle mass variability by genetic analysis. Biochemically, STC2 inhibits the proteolytic activity of the metalloproteinase PAPP‐A, which promotes muscle growth by upregulating the insulin‐like growth factor (IGF) axis. The aim was to examine if STC2 affects skeletal muscle mass and to assess how the IGF axis mediates muscle hypertrophy induced by functional overload.

Methods

We compared muscle mass and muscle fiber morphology between Stc2 −/− ( n = 21) and wild‐type ( n = 15) mice. We then quantified IGF1, IGF2, IGF binding proteins −4 and −5 (IGFBP‐4, IGFBP‐5), PAPP‐A and STC2 in plantaris muscles of wild‐type mice subjected to 4‐week unilateral overload ( n = 14).

Results

Stc2 −/− mice showed up to 10% larger muscle mass compared with wild‐type mice. This increase was mediated by greater cross‐sectional area of muscle fibers. Overload increased plantaris mass and components of the IGF axis, including quantities of IGF1 (by 2.41‐fold, p = 0.0117), IGF2 (1.70‐fold, p = 0.0461), IGFBP‐4 (1.48‐fold, p = 0.0268), PAPP‐A (1.30‐fold, p = 0.0154) and STC2 (1.28‐fold, p = 0.019).

Conclusion

Here we provide evidence that STC2 is an inhibitor of muscle growth upregulated, along with other components of the IGF axis, during overload‐induced muscle hypertrophy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin-Like Growth Factor Binding Protein 4Peptide HormonesAnimalsMiceGlycoproteinsHypertrophyInsulin-Like Growth Factor IMuscle, SkeletalPregnancy-Associated Plasma Protein-AIntercellular Signaling Peptides and Proteins

Stichwörter der Autor:innen

IGFSTC2resistance trainingskeletal muscle

Substanzen

GlycoproteinsInsulin-Like Growth Factor Binding Protein 4Insulin-Like Growth Factor IPeptide HormonesPregnancy-Associated Plasma Protein-AteleocalcinStc2 protein, mouseIntercellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.
  • Centre for Heart Lung Innovation, University of British Columbia, St. Paul's Hospital, Vancouver, Canada.
  • Department of Health Promotion and Rehabilitation, Lithuanian Sports University, Kaunas, Lithuania.
  • The New Zealand Institute for Plant & Food Research Limited, Palmerston North, New Zealand.
  • Animal Genetics Company (AnGeCo), Edinburgh, Scotland.
  • Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.

ORCID-Profile: Arimantas Lionikas

Förderung

  • Biotechnology and Biological Sciences Research Council
  • Wellcome Trust
  • Chief Scientist Office
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • Danmarks Frie Forskningsfond

Zitieren

APA

Lionikas, A., Hernandez Cordero, A. I., Kilikevicius, A., Carroll, A. M., Bewick, G. S., Bunger, L., Ratkevicius, A., Heisler, L. K., Harboe, M., & Oxvig, C. (2023). Stanniocalcin‐2 inhibits skeletal muscle growth and is upregulated in functional overload‐induced hypertrophy. Physiological Reports. https://doi.org/10.14814/phy2.15793

Vancouver

Lionikas A, Hernandez Cordero AI, Kilikevicius A, Carroll AM, Bewick GS, Bunger L, et al. Stanniocalcin‐2 inhibits skeletal muscle growth and is upregulated in functional overload‐induced hypertrophy. Physiological Reports. 2023. doi:10.14814/phy2.15793

BibTeX
@article{Lionikas2023,
  author = {Lionikas, Arimantas and Hernandez Cordero, Ana I and Kilikevicius, Audrius and Carroll, Andrew M and Bewick, Guy S and Bunger, Lutz and Ratkevicius, Aivaras and Heisler, Lora K and Harboe, Mette and Oxvig, Claus},
  title = {Stanniocalcin‐2 inhibits skeletal muscle growth and is upregulated in functional overload‐induced hypertrophy},
  journal = {Physiological Reports},
  year = {2023},
  doi = {10.14814/phy2.15793}
}
Kostenlos starten →